Here’s a pretty amazing story from ABC News about an exciting new treatment for an aggressive form of canine cancer called hemangiosarcoma:
Researchers are studying a Chinese mushroom compound that has shown some of the longest survival rates ever reported for dogs with hemangiosarcoma. Before this trial, a dog like Reuben could be expected to live 86 days, but the dogs on the mushroom compound are living beyond a year.
The coriolus versicolor mushroom, also known commonly as the Yunzhi mushroom, has been used for more than 2,000 years. Its active ingredient is polysaccharopeptide or PSP, and researchers believe it has immune-boosting properties and, more recently, tumor-fighting ability.
The research is being conducted at Penn Vet, which is part of the University of Pennsylvania Veterinary School in Philadelphia.